Syneron Profound for Acne Scars

How does Syneron Profound benefit the skin affected by acne scarring?

Syneron Profound System is a minimally invasive treatment for many conditions. Among other uses, it is successful in treating acne scars, even those deeper ones. Syneron Profound System is a bipolar radiofrequency device that is consisted of a hand piece similar to microneedling device or derma-pen. That hand piece has 5 micro-needles that are connected to electrodes. Those needles deliver bipolar radiofrequency to the deep dermis, encouraging production of elastin, collagen, and hyaluronic acid. By encouraging production of natural skin ingredients, aids skin healing and therefore it improves scars and overall skin appearance.

Syneron Profound System can be combined with different treatments to achieve desired results. It can be safely combined with chemical peels, laser, fillers, microdermabrasion, etc. It is important to always choose a board-certified and experienced provider who will space out your treatments accordingly to the pace at which patient’s skin heals. Spacing out treatments improves results and prevents further complications such as hyperpigmentation and scarring. So far, patients who decided to undergo Syneron Profound for acne scars are thrilled with their results, still, some side effects exist and it is important for providers to inform their patients about those before they undergo Syneron Profound System treatment.

The entire procedure is minimally invasive and it works by the principle of stimulating skin’s natural wound healing process. Desired results become visible within first two weeks after treatment. It is good for all skin types so it is safe for all people. There is minor discomfort during the procedure and it is usually described as warm and prickly sensation. There are minor side effects right after the treatment and those include sunburn appearance and burning sensation on treated areas. The skin is expected to fully heal after 4 weeks. Therefore, another procedure can be done after 4 weeks.